Summary
MetLife, Inc. filed this 8-K report on February 27, 2005, detailing the approval and impending grant of stock options and performance shares to its executive officers under the MetLife, Inc. 2005 Stock and Incentive Compensation Plan. These grants are set to become effective on April 15, 2005, contingent upon continued employment and the execution of formal agreements. The report specifies the number of options and performance shares allocated to key executives, including the Chairman and CEO Robert H. Benmosche. The exercise price for stock options will be determined by the closing stock price on April 15, 2005, while the performance shares have a three-year performance period from January 1, 2005, to December 31, 2007. This filing provides transparency into the company's executive compensation structure and its commitment to aligning executive interests with shareholder value through equity-based incentives.
Key Highlights
- 1MetLife's Board approved the grant of stock options and performance shares to executive officers under the 2005 Stock and Incentive Compensation Plan.
- 2Grants are effective April 15, 2005, and are contingent on continued employment and execution of agreements.
- 3The exercise price for stock options will be the closing stock price on April 15, 2005.
- 4Performance shares are subject to a performance period from January 1, 2005, to December 31, 2007.
- 5Specific allocations of options and performance shares are detailed for key executives, including CEO Robert H. Benmosche.
- 6The filing includes the forms of the Management Stock Option Agreement and Management Performance Share Agreement as exhibits.